Terns Pharmaceuticals (TERN) Q2 2026 Earnings

18MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.29
-0.28
-0.27
-0.25

Details

Expected EPS
-0.251667
Actual EPS
N/A
Surprise EPS
0.25
Surprise Percent
+100%

Description

Terns Pharmaceuticals (TERN) will report earnings of for Q2 2026 on May 18, 2026.

0 Comments

Share your thoughts